Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4 is a transmembrane glycoprotein expressed predominantly on the surface of helper T lymphocytes, and to a lesser extent on monocytes, macrophages, and dendritic cells. It acts as a co-receptor for MHC class II molecules, and is essential for the activation and differentiation of T cells during adaptive immune responses. CD4 facilitates cell signaling required for immune cell interactions, cytokine production, and B cell activation. It is also the primary receptor for HIV entry, making it a crucial therapeutic target in immunology and infectious disease. CD4^+ T cell subsets can differentiate into specialized effector functions (Th1, Th2, Th17, Treg, etc.), which orchestrate tailored immune responses to diverse pathogens and environmental stimuli.
Inhibition of CD4/HIV gp120 interaction (prevents HIV entry into helper T cells); Modulation of immune response by blocking, stimulating, or depleting CD4^+ cells; Targeted depletion of CD4^+ cells for immunosuppression in transplantation or autoimmune disorders
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4 (cluster of differentiation 4) (CD4).